|
Natco Pharma Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
14555.36 Cr.
|
P/BV
|
1.91
|
Book Value (Rs.)
|
424.71
|
|
52 Week High/Low (Rs.)
|
1505/727
|
FV/ML
|
2/1
|
P/E(X)
|
7.72
|
|
Bookclosure
|
20/11/2025
|
EPS (Rs.)
|
105.26
|
Div Yield (%)
|
0.74
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 105.26 | 77.34 | 39.18 | 9.32 | 24.20 |
| Diluted EPS (Rs.) | 105.26 | 77.34 | 39.18 | 9.32 | 24.16 |
| Cash EPS (Rs.) | 118.36 | 87.99 | 48.17 | 17.13 | 30.65 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 424.97 | 326.99 | 267.06 | 233.62 | 225.94 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 424.97 | 326.99 | 267.06 | 233.62 | 225.94 |
| Revenue From Operations / Share (Rs.) | 247.46 | 223.40 | 148.33 | 106.56 | 112.44 |
| PBDIT / Share (Rs.) | 142.49 | 105.00 | 57.00 | 19.86 | 38.89 |
| PBIT / Share (Rs.) | 129.35 | 94.56 | 48.02 | 12.05 | 32.49 |
| PBT / Share (Rs.) | 128.01 | 93.49 | 47.23 | 11.08 | 31.76 |
| Net Profit / Share (Rs.) | 105.22 | 77.56 | 39.19 | 9.31 | 24.24 |
| NP After MI And SOA / Share (Rs.) | 105.33 | 77.56 | 39.19 | 9.31 | 24.16 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 57.57 | 47.00 | 38.42 | 18.63 | 34.58 |
| PBIT Margin (%) | 52.27 | 42.33 | 32.37 | 11.30 | 28.89 |
| PBT Margin (%) | 51.73 | 41.85 | 31.83 | 10.39 | 28.24 |
| Net Profit Margin (%) | 42.51 | 34.71 | 26.42 | 8.74 | 21.55 |
| NP After MI And SOA Margin (%) | 42.56 | 34.71 | 26.42 | 8.74 | 21.48 |
| Return on Networth / Equity (%) | 24.78 | 23.71 | 14.67 | 3.98 | 10.69 |
| Return on Capital Employeed (%) | 30.11 | 28.52 | 17.61 | 4.99 | 13.89 |
| Return On Assets (%) | 21.84 | 20.10 | 12.64 | 3.32 | 9.20 |
| Total Debt / Equity (X) | 0.03 | 0.06 | 0.03 | 0.09 | 0.06 |
| Asset Turnover Ratio (%) | 0.57 | 0.63 | 0.50 | 0.36 | 0.35 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 5.59 | 4.14 | 4.39 | 3.52 | 4.45 |
| Quick Ratio (X) | 4.77 | 3.42 | 3.30 | 2.44 | 2.93 |
| Inventory Turnover Ratio (X) | 6.04 | 0.72 | 0.63 | 0.69 | 0.56 |
| Dividend Payout Ratio (NP) (%) | 5.70 | 12.25 | 14.03 | 48.29 | 25.81 |
| Dividend Payout Ratio (CP) (%) | 5.06 | 10.80 | 11.42 | 26.26 | 20.40 |
| Earning Retention Ratio (%) | 94.30 | 87.75 | 85.97 | 51.71 | 74.19 |
| Cash Earning Retention Ratio (%) | 94.94 | 89.20 | 88.58 | 73.74 | 79.60 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 106.72 | 97.89 | 71.74 | 20.48 | 53.37 |
| Interest Coverage Ratio (Post Tax) (%) | 79.80 | 73.31 | 50.33 | 10.60 | 34.26 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 12381.23 | 16442.15 | 9905.31 | 14018.63 | 15043.09 |
| EV / Net Operating Revenue (X) | 2.80 | 4.11 | 3.66 | 7.21 | 7.33 |
| EV / EBITDA (X) | 4.85 | 8.75 | 9.52 | 38.67 | 21.19 |
| MarketCap / Net Operating Revenue (X) | 3.22 | 4.26 | 3.80 | 7.11 | 7.34 |
| Retention Ratios (%) | 94.29 | 87.74 | 85.96 | 51.70 | 74.18 |
| Price / BV (X) | 1.88 | 2.91 | 2.11 | 3.24 | 3.65 |
| Price / Net Operating Revenue (X) | 3.22 | 4.26 | 3.80 | 7.11 | 7.34 |
| EarningsYield | 0.13 | 0.08 | 0.06 | 0.01 | 0.02 |
